American Thyroid Association Satellite Symposium 2020: Personalized Approach to Thyroid Disorders Part 2

CLICK "BEGIN" TO EVALUATE SESSIONS, CLAIM CME, DOWNLOAD PRESENTATION SLIDES, AND PRINT A CERTIFICATE OF ATTENDANCE OR CERTIFICATE OF PARTICIPATION.

Target Audience

This continuing medical education activity should be of substantial interest to the community of endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, trainees, nurses, physician assistants, other health care professionals and the general public who wish to broaden and update their knowledge on the thyroid.

Learning Objectives

Upon completion of this educational activity, learners will be able to:

  • Understand how to personalize management of thyroid disease in pregnancy.
  • Personalize the management of primary hypothyroidism of autoimmune origin and after thyroidectomy.
  • Optimize the options for management of thyrotoxicosis.
  • Risk-adapt the management of papillary microcarcinomas and other low risk well-differentiated thyroid cancers.
  • Tailor the treatment of advanced thyroid cancer based on molecular features, pathologic characteristics, and a risk-adapted approach.

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Medical Knowledge
Topic Area: 
Thyroid/HPT Axis
Level of Outcomes: 
Level 2 (Satisfaction)
Activity summary
Available credit: 
  • 3.00 ABIM MOC
  • 3.00 AMA PRA Category 1 Credits
Course opens: 
05/20/2020
Course expires: 
05/31/2021
Pricing: 
0
0
Rating: 
0

The management of thyroid disorders is becoming increasingly complex as clinicians and patients strive to develop individualized diagnostic and therapeutic strategies designed to balance evidence-based medicine with patient-specific characteristics and rising health care costs, while attempting to achieve excellent clinical outcomes. The goal of this Symposium is to provide participants the tools to design a personalized, patient-centered approach to the care of patients with thyroid disorders. The full program is outlined below:


Webinar #3Thyroid Disorders in Pregnancy (15 min)
  • Different TSH reference ranges according to ethnicity, BMI, other factors
  • Impact of autoimmunity in decision to treat 
  • Newborn outcomes 
Tim Korevaar
 

Hypothyroidism After Thyroidectomy and Autoimmune: Do We Treat It Differently? (15 min)

  • Thyroid hormone resistance: what is it and how to overcome it, and issues of thyroid hormone conversion and signaling 
  • Addition of T3? 
  • Surgery as strategy to treat autoimmune thyroid disease, eliminate TPO Abs, and quality of life issues 
Douglas Forrest 
Anne R. Cappola 
Rebecca S. Sippel 
 Hyperthyroidism: Personalized Therapeutic Options According to Etiology and Patient Preference (15 min)
  • RAI and risk of secondary malignancies 
  • Role of surgery: when and why 
  • Use of decision-aids in hyperthyroidism 
Cari Meinhold Kitahara 
Sarah Oltmann 
Susan C. Pitt 

 


 

Webinar #4Initial Approach to Low Risk Thyroid Cancer (20 min)
  • Use of decision-aids to proceed with active surveillance versus lobectomy versus total thyroidectomy (10 min)
  • How does molecular testing help in thyroid nodules when combined with ultrasound characteristics? (10 min)
Reese W. Randle 
Jennifer A. Sipos
 Approach to Advanced Thyroid Cancer (30 min)
  • When not to operate in advanced thyroid cancer (8-9 min)
  • How does molecular testing inform extent of initial surgery in low risk and high-risk lesions? (8-9 min)
  • Molecular-based therapies and redifferentiation trials (8-9 min)
Patrick Ha 
Masha Livhits 
Mabel M. Ryder

Laura Boucai, MD, Program Committee Co-Chair and Symposium Faculty
Memorial Sloan Kettering Cancer Center, New York, NY

Francesco S. Celi, MD, MHSc, Program Committee Co-Chair and Symposium Faculty
Virginia Commonwealth University, Richmond, VA

Anne R. Cappola, MD, ScM, Symposium Faculty
University of Pennsylvania School of Medicine, Philadelphia, PA

Ramona Dadu, MD, Program Committee Member and Symposium Faculty M.D.
Anderson Cancer Center, The University of Texas, Houston, TX

Douglas Forrest, PhD, Program Committee Member and Symposium Faculty
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD

Patrick Ha, MD, FACS, Symposium Faculty
University of California at San Francisco San Francisco, CA

Cari Meinhold Kitahara, PhD, Symposium Faculty
National Cancer Institute National Institutes of Health Bethesda, MD

Joanna Klubo-Gwiezdzinska, MD, PhD, MHSc, Program Committee Member
National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda, MD

Peter A. Kopp, MD, Program Committee Member
Northwestern University Chicago, IL University of Lausanne Lausanne, Switzerland

Tim Korevaar,MD, MSc, Symposium Faculty
Erasmus University Medical Center Rotterdam, Netherlands

Masha J. Livhits, MD, Symposium Faculty
David Geffen School of Medicine University of California, Los Angeles Los Angeles, CA

Sarah C. Oltmann, MD, FACS, Symposium Faculty
University of Texas Southwestern Dallas, TX

Maria Papaleontiou, MD, Program Committee Member and Symposium Faculty
University of Michigan Health System Ann Arbor, MI

Luca Persani, MD, PhD, Program Committee Member
University of Milan Milan, Italy

Susan C. Pitt, MD, Symposium Faculty
University of Wisconsin Madison, WI

Reese W. Randle, MD, FACS, Symposium Faculty
Wake Forest Baptist Health, Winston-Salem, NC

Jennifer E. Rosen, MD, FACS, Symposium Faculty
MedStar Washington Hospital Center Washington, DC

Mabel M. Ryder, MD, Symposium Faculty
Mayo Clinic Rochester, MN

Wendy Sacks, MD, Program Committee Member
Cedars-Sinai Medical Center Los Angeles, CA

Anna M. Sawka, MD, PhD, Symposium Faculty
University Health Network Toronto General Hospital Toronto, Ontario, Canada

Jennifer A. Sipos, MD, Symposium Faculty
The Ohio State University School of Medicine Columbus, OH

Rebecca S. Sippel, MD, FACS, Program Committee Member and Symposium Faculty
University of Wisconsin Madison, WI

Julie Ann Sosa, MD, MA, FACS, Symposium Faculty
University of California at San Francisco San Francisco, CA, USA

Martha A. Zeiger, MD, FACS, FACE, Program Committee Board Liaison and Symposium Faculty
National Cancer Institute National Institutes of Health Bethesda, MD

 

 

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The ATA 2020 Satellite Symposium faculty reported no relevant financial relationship(s) during the content development process for this activity:
Laura Boucai, MD; Francesco S. Celi, MD, MHSc; Anne R. Cappola, MD, ScM; Ramona Dadu, MD; Cari Meinhold Kitahara, PhD; Masha J. Livhits, MD; Sarah C. Oltmann, MD; Maria Papaleontiou, MD; Susan C. Pitt, MD; Reese W. Randle, MD, FACS; Jennifer E. Rosen, MD, FACS; Mabel M. Ryder, MD; Anna M. Sawka, MD, PhD; Rebecca S. Sippel, MD, FACS; Martha A. Zeiger, MD, FACS, FACE

The ATA 2020 Satellite Symposium faculty who have reported relevant financial relationship(s):

  • Patrick Ha, MD, FACS: Advisory Board, Loxo/Bayer Oncology; Primary Investigator, Stryker, Synthes, KLS Martin, Ethicon, Axogen
  • Tim Korevaar, MD: Speaker, Goodlife Healthcare, Berlin Chemie, Quidel
  • Jennifer A. Sipos, MD: Advisory Board, Eli Lilly
  • Julie Ann Sosa, MD, MA, FACS: Member, Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by GlaxoSmithKline, Novo Nordisk, Astra Zeneca and Eli Lilly, Institutional research funding from Exelixis and Loxo

The following SPC member who planned and reviewed content for this activity reported the following relevant financial relationships:

  • Angela M. Leung, MDSpeaker,Medical Education Resources, MCE Conferences

The following SPC Committee members reported financial relationships:

  • Andjela T. Drincic, MD: Advisory Board Member, Corcept
  • Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Esperion, AstraZeneca
  • Amy Rothberg, MD: Advisor, Rhythm Pharmaceuticals; Spouse, consultant of Merck

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:

  • Katherine Araque, MD; Beret Ann Casey, MD; Jenny Blau, MD; Neena Natt, MD; Lorena Alarcon-Casas Wright, MD; Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

Endocrine Society and the American Thyroid Association staff associated with the development of content for this activity reported no relevant financial relationships.

Click "Start" to complete the meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Endocrine Society and the American Thyroid Association. The Endocrine Society is accredited by the ACCME to provide continuing medical education for physicians.

The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credit™ and 3.00 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

As an accredited provider of Continuing Medical Education (CME) by the Accreditation Council for Continuing Medical Education (ACCME), the Endocrine Society is also able to provide Maintenance of Certification (MOC) points through the ABIM MOC Assessment Recognition Program. As such, the Endocrine Society ensures that activities registered by the Society for ABIM MOC recognition meet the requirements for all MOC activities as defined by the American Board of Internal Medicine (ABIM). The Endocrine Society is responsible for submitting participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at education.endocrine.org/contact.

MAINTENANCE OF CERTIFICATION
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

REVIEW YOUR DIPLOMATE ABIM ID NUMBER(S)
In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

  • Provide your board-certification information in your educational profile. Your profile currently contains the following board ID numbers (must be logged in to view):
    Your ABIM Number: *

*If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.

UPDATE YOUR PROFILE

Available Credit

  • 3.00 ABIM MOC
  • 3.00 AMA PRA Category 1 Credits